
Imatinib - Wikipedia
Imatinib, sold under the brand names Gleevec and Glivec (both marketed worldwide by Novartis) among others, is an oral targeted therapy medication used to treat cancer. [2] Imatinib is a small molecule inhibitor targeting multiple tyrosine kinases such as CSF1R, ABL, c …
Imatinib Information for Patients - Drugs.com
Dec 11, 2024 · Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer. Includes imatinib side effects, interactions, and indications.
Imatinib - StatPearls - NCBI Bookshelf - National Center for ...
Jun 20, 2023 · Imatinib is a 2-phenylamino-pyrimidine derivative protein that is a medication used to manage and treat chronic myelogenous leukemia, gastrointestinal stromal tumors, and other malignancies. It is in the tyrosine-kinase inhibitors class of drugs.
Imatinib (oral route) - Mayo Clinic
Apr 1, 2025 · Imatinib is used alone or together with other medicines to treat different types of cancer or bone marrow conditions. It prevents or stops the growth of cancer cells and is called an antineoplastic (cancer) agent.
Imatinib MESYLATE - Uses, Side Effects, and More - WebMD
Find patient medical information for imatinib oral on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings.
Imatinib (Gleevec®): Uses & Side Effects - Cleveland Clinic
IMATINIB (i MAT in ib) is a medicine that targets proteins in cancer cells and stops the cancer cells from growing. It is used to treat certain leukemias, myelodysplastic syndromes, and other cancers. It is also used to treat specific digestive tract tumors called GISTs.
Imatinib: A Breakthrough of Targeted Therapy in Cancer - PMC
Imatinib, an oral targeted therapy, inhibits tyrosine kinases specifically BCR-ABL, c-KIT, and PDGFRA. Apart from its remarkable success in CML and GIST, Imatinib benefits various other tumors caused by Imatinib-specific abnormalities of PDGFR and c-KIT.
Imatinib Mesylate - NCI - National Cancer Institute
Imatinib mesylate is approved to treat: Acute lymphoblastic leukemia in adults and children that is Philadelphia chromosome positive. In adults, it is used for cancer that has come back or does not respond to treatment. In children, it is used with chemotherapy as the first treatment after the cancer is diagnosed.
Imatinib: MedlinePlus Drug Information
Imatinib is in a class of medications called kinase inhibitors. It works by blocking the action of an abnormal protein in cancer cells. This helps slow or stop the spread of cancer cells. How should this medicine be used? Imatinib comes as a tablet and a solution (liquid) to take by mouth.
Imatinib - Macmillan Cancer Support
Imatinib is a targeted therapy. It is used to treat some types of leukaemia, blood disorders and gastro-intestinal stromal tumours called GISTs. What is imatinib? Imatinib is used to treat: blood disorders, such as advanced hypereosinophilic syndrome (HES) and chronic eosinophilic leukaemia (CEL). Imatinib may also be used to treat: